ASCO 2018: Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (I

Page analysis provided by Secret Search Engine Labs

ASCO 2018: Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (I
clin.larvol.com

Copyright © LARVOL 2024. All rights reserved.

Visit ASCO 2018: Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (I (https://clin.larvol.com/abstract-detail/ASCO%202018/24884502)

CashRank™: $0.00
Tags:
Level: 0

Alexa Traffic Rank™: N/A
Google PageRank™: N/A

Top Keywords: 2018, asco 2018, asco, with nivolumab, therapy with, adjuvant therapy, nivolumab, ipilimumab, nivo, versus, adjuvant, therapy, trials, influencers, conferences, iii, reserved, terms of service, of service, all rights reserved, figures for, after complete, of stage, a phase, resection of, iii iv, phase iii, stage iii, rights reserved, all rights, results from, resection, i, a, checkmate, melanoma, Theres a total of 51 keywords.

Inbound and Outbound Links

There is currently no known inbound links. There is currently no known outbound links.

View link details

Statistics

We first found this page on 2023-03-17 00:00:07 +0000. It was last re-indexed on 2024-09-23 13:34:13 +0000 and with a fetch interval of 90 days it will be fetched again in 29 days on 2024-12-22 or soon thereafter.

Last fetch returned code 200, OK, the current page state is ACTIVE.

Traffic Data for clin.larvol.com

Traffic data is only available for sites with a CashRank of $15 or better, an Alexa rank better than 100,000 or PageRank of 2 or more.

If you are the owner of /clin.larvol.com and you want to remove this page from the search results, just use robots.txt

Similar Sites

pegilodecakin (LY3500518) / Eli Lilly

News for pegilodecakin (LY3500518) / Eli Lilly
https://delta.larvol.com/Products/?ProductId=f19283c2-cc63-4231-8e15-ec0207605e0f - Details - Similar

ASCO-GU 2022: Intestinal microbiome associated with development of gra

Copyright © LARVOL 2024. All rights reserved.
https://clin.larvol.com/abstract-detail/ASCO-GU%202022/53709436 - Details - Similar

letetresgene autoleucel (GSK3377794) / Adaptimmune

News for letetresgene autoleucel (GSK3377794) / Adaptimmune
https://delta.larvol.com/Products/?ProductId=820f7bec-269a-4386-84a9-9a882752b452 - Details - Similar

ASCO 2018: Factors associated with duration of response after CD19-spe

Copyright © LARVOL 2024. All rights reserved.
https://clin.larvol.com/abstract-detail/ASCO%202018/24882355 - Details - Similar

More sites similar to ASCO 2018: Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (I...

Find Another Website

Search - Add URL

Sponsored Results

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less

web stats

Copyright (C) 2007 - 2024 Text Ad King and SecretSearchEngineLabs.com. All Rights Reserved.
Terms and Conditions - Privacy Policy - Advertising - About Us - Login